Join to View Full Profile
243 Charles StBoston, MA 02114
Phone+1 203-688-2259
Fax+1 203-688-5599
Dr. Zebardast is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Johns Hopkins UniversityResidency, Ophthalmology, 2014 - 2017
Yale-New Haven Medical CenterInternship, Transitional Year, 2013 - 2014
Yale School of MedicineClass of 2012
Certifications & Licensure
MA State Medical License 2018 - 2025
MD State Medical License 2017 - 2019
American Board of Ophthalmology Ophthalmology
Publications & Presentations
PubMed
- Pyruvate and related energetic metabolites modulate resilience against high genetic risk for glaucoma.Keva Li, Nicholas Tolman, Ayellet V Segrè, Kelsey V Stuart, Oana A Zeleznik
Elife. 2025-04-24 - Genetic risk for open angle glaucoma subtypes is associated with specific visual field defect classes.Sayuri Sekimitsu, Kavin Selvan, Yan Zhao, Saber Kazeminasab Hashemabad, Mohammad Eslami
Ophthalmology. 2025-04-11 - Association Between Cup-to-Disc Ratio and Structural and Functional Damage Parameters in Glaucoma: Insights From Multiparametric Modeling.Aliah McCalla, Mengyu Wang, Mohammad Eslami, Saber Kazeminasab, Yan Luo
Translational Vision Science & Technology. 2025-04-01
Journal Articles
- Effect of a Schlemm’s Canal Microstent on Early Post-Operative IOP Following Cataract Surgery: An Analysis of the HORIZON Randomized Controlled TrialNazlee Zebardast, MD, Ophthalmology
Press Mentions
AI, Deep Learning Start to Tackle Common Problems in HealthcareApril 9th, 2019
Microstent Reduces Post-Cataract Surgery Intraocular Pressure in Glaucoma PatientsFebruary 21st, 2020
Retinal Imaging and Genetics Data Used to Predict Future Disease RiskJanuary 25th, 2024- Join now to see all
Grant Support
- Enhancing Glaucoma Risk Prediction through Advanced Genomics and Machine LearningMASSACHUSETTS EYE AND EAR INFIRMARY2024–2029
- Enhancing Glaucoma Risk Prediction through Advanced Genomics and Machine LearningMASSACHUSETTS EYE AND EAR INFIRMARY2024–2029
- Glaucoma Risk Prediction Using Machine Learning Integration of Image-Based Phenotypes and Genetic AssociationsMASSACHUSETTS EYE AND EAR INFIRMARY2021–2025
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
